110P Real-world evaluation of pembrolizumab monotherapy for previously treated PD-L1 positive (TPS>1%) advanced NSCLC in France

Autor: Pérol, M., Quantin, X., Lena, H., Filleron, T., Chouaid, C., Valette, C. Audigier, Kaderbhai, C., Chenuc, G., Santorelli, M., Bensimon, L., Burke, T., Simon, G., Martin, A-L., Debieuvre, D., Gervais, R., Schott, R., Carton, M., Courtinard, C., Girard, N.
Zdroj: In Journal of Thoracic Oncology April 2021 16(4) Supplement:S758-S758
Databáze: ScienceDirect